PPD Inc. (PPD): Price and Financial Metrics


PPD Inc. (PPD): $46.10

-0.05 (-0.11%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

PPD POWR Grades


  • Growth is the dimension where PPD ranks best; there it ranks ahead of 96.84% of US stocks.
  • The strongest trend for PPD is in Growth, which has been heading up over the past 153 days.
  • PPD ranks lowest in Momentum; there it ranks in the 36th percentile.

PPD Stock Summary

  • PPD Inc's capital turnover -- a measure of revenue relative to shareholder's equity -- is better than just 1.69% of US listed stocks.
  • PPD's went public 1.25 years ago, making it older than just 0.64% of listed US stocks we're tracking.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at -7.26 for PPD Inc; that's greater than it is for merely 2.21% of US stocks.
  • Stocks that are quantitatively similar to PPD, based on their financial statements, market capitalization, and price volatility, are HLF, UI, LB, AAL, and SNBR.
  • Visit PPD's SEC page to see the company's official filings. To visit the company's web site, go to www.ppdi.com.

PPD Price Target

For more insight on analysts targets of PPD, see our PPD price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $46.67 Average Broker Recommendation 1.96 (Hold)

PPD Stock Price Chart Interactive Chart >

Price chart for PPD

PPD Price/Volume Stats

Current price $46.10 52-week high $46.49
Prev. close $46.15 52-week low $24.75
Day low $46.08 Volume 3,152,300
Day high $46.20 Avg. volume 2,551,441
50-day MA $40.17 Dividend yield N/A
200-day MA $35.77 Market Cap 16.18B

PPD Inc. (PPD) Company Bio


Pharmaceutical Product Development LLC is a leading global contract research organization providing drug discovery, development, lifecycle management and laboratory services. Its services include contact services, discovery, early development, clinical development, laboratories, post-approval, PPD consulting and industry expertise. The firm operates in the therapeutic areas that include cardiovascular, critical care, dermatology, dental pain research, endocrine and metabolics, gastroenterology, hematology and oncology, immunology, infectious diseases, neuroscience, ophthalmology, respiratory and urology. The company was founded in 1985 by Fredric N. Eshelman and is headquartered in Wilmington, NC.


PPD Latest News Stream


Event/Time News Detail
Loading, please wait...

PPD Latest Social Stream


Loading social stream, please wait...

View Full PPD Social Stream

Latest PPD News From Around the Web

Below are the latest news stories about PPD Inc that investors may wish to consider to help them evaluate PPD as an investment opportunity.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Continues to Investigate PPD, GFN, KNL, TRMT; Shareholders are Encouraged to Contact the Firm

NEW YORK, May 03, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: PPD, Inc. (NASDAQ: PPD) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Thermo Fisher Scientific Inc. for $47.50 per share. If you are a PPD shareholder, click here to learn more about your rights and options. General Finance Corporation (NASDAQ: GFN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to United Rentals, Inc. for $19.00 per share in cash. If you are a General Finance shareholder, click here to learn more about your rights and options. Knoll, Inc. (NYSE: KNL) concerning potential vi...

Yahoo | May 3, 2021

PPD, Inc. (PPD) Q1 2021 Earnings Call Transcript

At this time, I'd like to turn the conference over to Tracy Krumme, vice president and head of investor relations for PPD. Krumme, you may begin. With me today to share our results are David Simmons, PPD's chairman and CEO; and Chris Scully, our CFO.

Yahoo | April 28, 2021

PPD to Expand GMP Lab in Ireland to Enhance Biopharmaceutical Testing Capabilities

PPD is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory

Yahoo | April 28, 2021

PPD Inc to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / April 28, 2021 / PPD Inc (NASDAQ:PPD) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on April 28, 2021 at 8:00 AM Eastern Time.To listen to the event live or access a replay of the call - visit https://www.

Yahoo | April 28, 2021

PPD, Inc. (PPD) Q1 Earnings and Revenues Top Estimates

PPD, Inc. (PPD) delivered earnings and revenue surprises of 12.90% and 6.79%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | April 27, 2021

Read More 'PPD' Stories Here

PPD Price Returns

1-mo 20.37%
3-mo 29.60%
6-mo 38.19%
1-year 68.00%
3-year N/A
5-year N/A
YTD 34.72%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6881 seconds.